Fig 1.
The flow chart of the chronic hepatitis patients enrolled into this study.
MetS represents metabolic syndrome.
Fig 2.
Total patients and chronic hepatitis C (CHC) patients coexisted with MetS had significant higher liver stiffness level than those without (8.7kPa vs 6.5 kPa, p = 0.01; 10.7 kPa vs 7.3 kPa, p = 0.049, respectively).
Although chronic hepatitis B (CHB) patients coexisted with Mets also had higher liver stiffness level than those without, the difference was not significant (7.3 kPa vs 5.9 kPs, p = 0.138).
Table 1.
Baseline characteristics of enrolled 395 patients.
Table 2.
Baseline characteristics of enrolled 228 CHB patients.
Table 3.
Baseline characteristics of enrolled 150 CHC patients.
Table 4.
Logistic regression analysis of factors associated with metabolic syndrome for enrolled total patients, chronic hepatitis B patients and chronic hepatitis C patients.